CMS considers easing PET reimbursement for most cancers

03/15/2013 | AuntMinnie.com (free registration)

CMS has released a decision memo with a proposal to lift the requirement that FDG-PET scans in cases involving solid tumors be reported to the National Oncologic PET Registry. Providers will no longer have to send the data to the registry as a reimbursement condition if the proposal is approved. CMS said it will reimburse one FDG-PET or PET/CT scan used to assess initial cancer therapy for most indications except prostate cancer. Coverage for subsequent scans will be determined by local Medicare contractors, CMS said.

View Full Article in:

AuntMinnie.com (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN